12-羟基硬脂酸乙酯 | 74815-67-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 12-羟基硬脂酸乙酯
• 英文名称: ethyl 12-hydroxystearate
• 英文别名: 12-hydroxystearic acid ethyl ester；ethyl 12-hydroxyoctadecanoate；12-hydroxy-octadecanoic acid ethyl ester；12-Hydroxy-octadecansaeure-aethylester；12-Hydroxy-stearinsaeure-aethylester
• CAS: 74815-67-1
• 化学式: C₂₀H₄₀O₃
• 分子量: 328.536
• InChiKey: FAUQJFRSOKONGU-UHFFFAOYSA-N

物化性质

• 熔点：
  51-51.3 °C
• 沸点：
  180-185 °C(Press: 1 Torr)
• 密度：
  0.912±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7
• 重原子数：
  23
• 可旋转键数：
  18
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  12-羟基硬脂酸乙酯 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 6.0h， 以96%的产率得到12-羟基硬脂酸
  参考文献：
  名称：

  Zakharkin, L. I.; Guseva, V. V.; Churilova, I. M., Journal of Organic Chemistry USSR (English Translation), 1983, vol. 19, p. 1632 - 1634

  摘要：

  DOI：
• 作为产物：
  描述：

  ethyl 12-oxo-octadecanoate 在 镍 氢气 作用下， 以 乙醇 为溶剂， 反应 15.0h， 以91%的产率得到12-羟基硬脂酸乙酯
  参考文献：
  名称：

  Zakharkin, L. I.; Guseva, V. V.; Churilova, I. M., Journal of Organic Chemistry USSR (English Translation), 1983, vol. 19, p. 1632 - 1634

  摘要：

  DOI：

文献信息

• Amine derivative and dermatologic preparation containing the same
  申请人：Kao Corporation

  公开号：US05723497A1

  公开（公告）日：1998-03-03

  The present invention relates to an amine derivative represented by the following general formula (I) or (II): ##STR1## wherein R.sup.1 means a heteroatom-containing C.sub.1 -C.sub.40 hydrocarbon group which may have a ring structure, or the like; R.sup.2 -R.sup.5 each denote a C.sub.1 -C.sub.20 hydrocarbon group, hydrogen or the like; A.sup.1 represents ##STR2## or R.sup.15 --Z--.sup.16 --(CH.sub.2).sub.n --; B.sup.1 stands for hydrogen, a C.sub.1 -C.sub.10 hydrocarbon group, nitrogen or the like; C.sup.1 denotes hydrogen, a C.sub.1 -C.sub.10 hydrocarbon group, nitrogen, alcohol residue, phosphoric acid residue or the like; a dermatologic preparation containing the same; and a process for producing the amine derivative. This amine derivative has excellent effects of smoothing or removing wrinkles and improving keratinization.

  本发明涉及一种由以下一般式(I)或(II)表示的胺衍生物：其中R.sup.1表示可能具有环结构的含杂原子的C.sub.1 -C.sub.40碳氢基团，或类似物；R.sup.2 -R.sup.5各自表示C.sub.1 -C.sub.20碳氢基团、氢或类似物；A.sup.1表示##STR2##或R.sup.15 --Z--.sup.16 --(CH.sub.2).sub.n --；B.sup.1代表氢、C.sub.1 -C.sub.10碳氢基团、氮或类似物；C.sup.1表示氢、C.sub.1 -C.sub.10碳氢基团、氮、醇残基、磷酸残基或类似物；一种含有该胺衍生物的皮肤科制剂；以及生产该胺衍生物的方法。该胺衍生物具有出色的平滑或去皱效果，改善角化作用。
• [EN] NEW NON-IONIC SURFACTANTS FOR SOLUBILIZING POORLY SOLUBLE MOLECULES<br/>[FR] NOUVEAUX TENSIOACTIFS NON IONIQUES DESTINES A SOLUBILISER DES MOLECULES FAIBLEMENT SOLUBLES
  申请人：ASTRAZENECA AB

  公开号：WO2004089869A1

  公开（公告）日：2004-10-21

  New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene / alkyl polyoxyalkylene chain with a chain-length of 25 - 455 repeating units and a specified substituent on the hydroxy position of the specified hydroxy fatty acid, according to the general formula (I) CH3 - (CH2)x - CH - (CH2)y - CO - [-O - R3 - ]z - O - R1 R2 - O (I); wherein for example R1 is methyl, R2 is optionally substituted C14 - C22 acyl, alkyl, or alkenyl, R3 is ethylene, x is 2-12, y is 7-17, (x + y) is 3-19 and z is 25-57; advantageously prepared by involving an enzymatic process, formulations comprising them, their use as solubilizers and a process involving a hydrolytic enzyme for preparing them.

  新的非离子表面活性剂以聚氧烷基乙二醇羟基脂肪酸衍生物或单烷基化聚氧烷基乙二醇羟基脂肪酸衍生物的形式存在，具有聚氧烷基/烷基聚氧烷基链，链长为25-455个重复单元，并且在指定的羟基脂肪酸的羟基位置上具有特定的取代基，根据通式（I）CH3 -（CH2）x - CH -（ ）y - CO - [-O - R3 -]z - O - R1 R2 - O（I）；例如，其中R1为甲基，R2为可选的取代的C14 - C22酰基、烷基或烯基，R3为乙烯基，x为2-12，y为7-17，（x + y）为3-19，z为25-57；通过涉及酶过程有利地制备，包含它们的配方，它们作为溶剂的用途以及涉及水解酶制备它们的过程。
• Amide derivatives and dermatologic preparations containing the same
  申请人：Kao Corporation

  公开号：US05221757A1

  公开（公告）日：1993-06-22

  An amide derivative represented by the following general formula (II): ##STR1## (wherein R.sup.3 represents a straight-chain or branched, saturated or unsaturated hydrocarbon group carrying 10 to 40 carbon atoms; R.sup.4 represents a straight-chain or branched hydrocarbon group carrying 3 to 39 carbon atoms; and R.sup.5 represents a hydrogen atom, a straight-chain or branched, saturated or unsaturated hydrocarbon group carrying 10 to 40 carbon atoms or an acyl group); and a dermatologic preparation containing the same.

  由以下一般公式（II）表示的酰胺衍生物：##STR1##（其中R.sup.3代表带有10至40个碳原子的直链或支链、饱和或不饱和碳氢基团；R.sup.4代表带有3至39个碳原子的直链或支链碳氢基团；R.sup.5代表氢原子、带有10至40个碳原子的直链或支链、饱和或不饱和碳氢基团或酰基）；以及含有该化合物的皮肤科制剂。
• Non-ionic surfactants for solubilizing poorly solubule molecules
  申请人：von Corswant Christian

  公开号：US20060287542A1

  公开（公告）日：2006-12-21

  New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene / alkyl polyoxyalkylene chain with a chain-length of 25-455 repeating units and a specified substituent on the hydroxy position of the specified hydroxy fatty acid, according to the general formula (I) CH 3 —(CH 2 ) x —CH—(CH 2 ) y —CO—[—O—R 3 —] z —O—R 1 R 2 —O (I); wherein for example R 1 is methyl, R 2 is optionally substituted C 14 —C 22 acyl, alkyl, or alkenyl, R 3 is ethylene, x is 2-12, y is 7-17, (x+y) is 3-19 and z is 25-57; advantageously prepared by involving an enzymatic process, formulations comprising them, their use as solubilizers and a process involving a hydrolytic enzyme for preparing them.

  新的非离子表面活性剂采用聚氧烷基乙二醇羟基脂肪酸衍生物或单烷基化聚氧烷基乙二醇羟基脂肪酸衍生物形式，具有聚氧烷基/烷基聚氧烷基链，链长为25-455个重复单元，并且在指定羟基脂肪酸的羟基位置上具有指定的取代基，按照通式(I) CH3—(CH2)x—CH—( )y—CO—[—O—R3—]z—O—R1R2—O (I)；其中，例如R1为甲基，R2为可选取代的C14-C22酰基，烷基或烯基，R3为乙烯，x为2-12，y为7-17，(x+y)为3-19，z为25-57；通过涉及酶法的方法优选制备，包含它们的配方，它们作为溶解剂的用途以及涉及水解酶制备它们的方法。
• Non-ionic surfactants for poorly soluble molecules
  申请人：AstraZeneca AB

  公开号：US07491836B2

  公开（公告）日：2009-02-17

  New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene/alkyl polyoxyalkylene chain with a chain-length of 25-455 repeating units and a specified substituent on the hydroxy position of the specified hydroxy fatty acid, according to the general formula (I) CH3—(CH2)x—CH—(CH2)y—CO—[—O—R3—]z—O—R1 R2—O (I); wherein for example R1 is methyl, R2 is optionally substituted C14-C22 acyl, alkyl, or alkenyl, R3 is ethylene, x is 2-12, y is 7-17, (x+y) is 3-19 and z is 25-57; advantageously prepared by involving an enzymatic process, formulations comprising them, their use as solubilizers and a process involving a hydrolytic enzyme for preparing them.

  新的非离子表面活性剂以聚氧烷基乙二醇羟基脂肪酸衍生物或单烷基化聚氧烷基乙二醇羟基脂肪酸衍生物的形式存在。该衍生物具有聚氧烷基/烷基聚氧烷基链，链长为25-455个重复单元，并且在指定羟基脂肪酸的羟基位置上有指定的取代基，符合通式(I) CH3—(CH2)x—CH—( )y—CO—[—O—R3—]z—O—R1 R2—O (I)。例如，其中R1为甲基，R2为可选的取代C14-C22酰基，烷基或烯基，R3为乙烯，x为2-12，y为7-17，(x+y)为3-19，z为25-57。通过涉及酶法的方法优选制备，包括它们的配方，它们作为溶解剂的用途以及涉及水解酶的过程用于制备它们。